Research impact

We are revolutionising the way endometriosis is diagnosed by developing a reliable, fast and non-invasive tool that harnesses medical imaging and artificial intelligence to facilitate successful fertility treatments.

Our work is set to increase success rates of assisted reproduction, such as in-vitro fertilisation (IVF). Our researchers are developing novel techniques to assess sperm quality at an unprecedented level and harness light to determine the developmental potential of embryos non-invasively.

We are investigating how environmental factors, such as exposures to different chemicals and pollutants, can negatively impact pregnancy outcomes and longer-term child health by developing new diagnostic tools and treatments designed to reduce the risk of poor pregnancy outcomes such as miscarriage and preterm birth.

Our researchers have changed the understanding of causes of neurodevelopmental disabilities, such as Cerebral Palsy. Ongoing work is determining how early genetic testing and diagnosis can improve long-term health outcomes for children with neurodevelopmental disabilities.

Our clinical research teams run world-first trials to improve care and treatment pathways for babies born prematurely. We have improved neonatal medicine and guidelines for care, helping the most vulnerable to have a better start and improved long-term health, free of neurodevelopmental impairment.

Our researchers have partnered to invent ground-breaking lung imaging technology, allowing for unparalleled precision, early detection, and highly targeted treatment of children with lung diseases, such as Cystic Fibrosis (CF). We are now conducting important studies to understand how gene therapy might be used for altering CF-related lung and airway health.